We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,258.00
Bid: 3,257.00
Ask: 3,258.00
Change: 1.00 (0.03%)
Spread: 1.00 (0.031%)
Open: 3,262.00
High: 3,262.00
Low: 3,246.00
Prev. Close: 3,257.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian agrees to acquire Compuscan

10 Dec 2018 13:30

RNS Number : 9966J
Experian plc
10 December 2018
 

 

news release

 

 

Experian agrees to acquire Compuscan, extending our bureau presence in Africa

 

10 December 2018 - Experian, the global information services company, is pleased to announce that it has agreed to acquire Compuscan (CSH Group (Pty) Limited), one of the leading credit bureau and information services businesses in Africa.

 

Brian Cassin, Chief Executive Officer said:

 

"We are delighted to announce that Experian has agreed to acquire Compuscan. We have a long track record of investment in South Africa, where for many years we have helped businesses thrive through the provision of credit data and decisioning tools. Millions of people across Africa need access to financial services. By combining forces with Compuscan, we will be better positioned to serve the people and businesses of this region and be an enabler of growth in consumer and business credit, identity management and financial inclusion. This is an important transaction for our business in South Africa and will provide opportunities more broadly across the African continent. We look forward to welcoming the Compuscan team to Experian."

 

Overview of Compuscan

 

Founded in 1994, Compuscan is one of the leading providers of credit information and decision analytics in South Africa, with operations across seven key geographies in Sub-Saharan Africa. Compuscan also provides marketing services and has recently launched a free credit report service for consumers.

 

By combining Experian and Compuscan, we will enhance the services we can provide to our B2B customers and consumers, as well as delivering substantial operational synergies. In addition to deepening our bureau data assets, Compuscan has particular strength in analytics and scores, which is highly complementary to Experian's strength in decisioning software. We will also be better positioned to leverage our continuing investment in innovation to combine the best of Experian with that of Compuscan to bring the latest and most competitive credit assessment tools to the African market. For example, we have recently introduced our big data analytics platform Ascend to financial services and telecommunications clients in South Africa and likewise see potential to expand Compuscan's nascent position in providing services to consumers. Compuscan holds credit information on 26 million people and 200,000 businesses in South Africa, representing approximately 56% of the population.

 

The combined customer bases will also be highly complementary. Experian's customers in South Africa are mainly large financial institutions and telecommunications operators, while Compuscan has an attractive position in the dynamic microlending space, as well as in the retail and insurance sectors.

 

Financial information

 

We have agreed to acquire 100% of Compuscan for a cash consideration of R3,720m (c.US$263m*) payable on completion. The transaction is expected to be funded from existing cash resources. The transaction is subject to approval by the Competition Commission in South Africa. It is expected to complete during the first quarter of financial year ending 31 March 2020.

 

For the year ending 31 December 2018, Compuscan is expected to generate R489 million (US$35 million) in revenue, growing to R532 million (US$38 million) in the year ending 31 December 2019. This compares to Experian revenues in South Africa of around US$40m. We expect the transaction to be accretive to Benchmark EPS in its first full year of ownership.

 

* ZAR/US$ exchange rate of 14.17 as at 10 December 2018.

Contact:

Experian

Nadia Ridout-Jamieson Investors +44 (0)20 3042 4215

Gerry Tschopp Media +1 714 830 7756

 

Finsbury

Rollo Head +44 (0)20 7251 3801

Jenny Davey

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 16,500 people operating across 39 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQEADAEFFLPFFF
Date   Source Headline
30th Sep 202212:06 pmRNSTotal Voting Rights
28th Sep 20229:02 amRNSAdditional Listing
19th Sep 202210:00 amRNSBlock listing Interim Review
14th Sep 20229:30 amRNSAdditional Listing
7th Sep 20229:30 amRNSAdditional Listing
31st Aug 202210:07 amRNSTotal Voting Rights
31st Aug 20229:30 amRNSAdditional Listing
17th Aug 20229:30 amRNSAdditional Listing
10th Aug 20229:15 amRNSAdditional Listing
29th Jul 20229:57 amRNSTotal Voting Rights
28th Jul 20229:25 amRNSDirector/PDMR Shareholding
21st Jul 202211:15 amRNSResult of AGM
21st Jul 202210:30 amRNSDirector Declaration
20th Jul 20229:30 amRNSAdditional Listing
14th Jul 20227:00 amRNSTrading update, first quarter
1st Jul 20225:42 pmRNSSecond Interim Dividend
30th Jun 20225:50 pmRNSTransaction in Own Shares
30th Jun 20224:00 pmRNSDirector/PDMR Shareholding
30th Jun 202210:54 amRNSTotal Voting Rights
29th Jun 20225:12 pmRNSTransaction in Own Shares
28th Jun 20225:28 pmRNSTransaction in Own Shares
27th Jun 20225:14 pmRNSTransaction in Own Shares
27th Jun 20222:15 pmRNSHolding(s) in Company
24th Jun 20225:41 pmRNSTransaction in Own Shares
24th Jun 202210:51 amRNSDirector/PDMR Shareholding
23rd Jun 20225:19 pmRNSTransaction in Own Shares
22nd Jun 20225:50 pmRNSTransaction in Own Shares
20th Jun 20225:26 pmRNSTransaction in Own Shares
17th Jun 20225:10 pmRNSTransaction in Own Shares
16th Jun 20225:33 pmRNSTransaction in Own Shares
15th Jun 20226:29 pmRNSTransaction in Own Shares
15th Jun 20225:36 pmRNSTransaction in Own Shares
15th Jun 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 20223:39 pmRNSAnnual Financial Report
10th Jun 202210:00 amRNSElections for second interim dividend
9th Jun 20224:15 pmRNSDirector/PDMR Shareholding
31st May 202211:42 amRNSTotal Voting Rights
26th May 20225:08 pmRNSTransaction in Own Shares
25th May 20225:43 pmRNSTransaction in Own Shares
24th May 20225:22 pmRNSTransaction in Own Shares
23rd May 20225:41 pmRNSTransaction in Own Shares
20th May 20225:35 pmRNSTransaction in Own Shares
19th May 20225:38 pmRNSTransaction in Own Shares
18th May 20226:15 pmRNSTransaction in Own Shares
18th May 202211:30 amRNSShare repurchases
18th May 20227:00 amRNSFull-year financial report
16th May 20227:00 amRNSExperian agrees to acquire majority stake in MOVA
29th Apr 202212:01 pmRNSTotal Voting Rights
6th Apr 20229:35 amRNSAdditional Listing
31st Mar 20221:35 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.